Deep Vein Thrombosis Market Projected to Ascend to $1.26 billion by 2028: A Fresh Global Market Report Unveiled
29 janv. 2024 18h55 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Deep Vein Thrombosis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. An extensive global market report on...
Acquired Orphan Blood Disease Market Research Reveals Rapid Growth in Asia and Innovative Therapies
25 janv. 2024 05h39 HE | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Acquired Orphan Blood Disease Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Global Thrombosis and Hemostasis Biomarkers Market
Thrombosis And Hemostasis Biomarkers Research Report 2023: Point-of-Care Analyzers Gain Traction - Global Forecast to 2030
22 nov. 2023 07h18 HE | Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Thrombosis And Hemostasis Biomarkers Market Size, Share & Trends Analysis Report By Product (Analyzers, Reagents & Consumables), By Test...
Vascular Closure Device Market Share Worth $2.80 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
08 nov. 2023 08h53 HE | The Insight Partners
Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) -- A vascular closure device is a piece of collagen (a fibrous protein found in skin, connective tissue, and bone), a metallic clip, or a suture designed...
Anthos Logo Transparent.png
Anthos Therapeutics Supported Global Survey of 3000+ Patients Prescribed Anticoagulants Detailing Impact of Patient-Relevant Bleeding (PRB) Presented at ISTH 2023
26 juin 2023 07h00 HE | Anthos Therapeutics
Patient-Centric Survey Conducted in Collaborationwith StopAfib.org and the National Blood Clot Alliance Findings Suggest “Patient-Relevant Bleeding” More Accurate Than Current Terminology,...
MicrosoftTeams-image (5).png
Bare-metal Stents Market to Achieve Remarkable Growth, Projected at 5.2% CAGR, and Surpassing USD 4.8 Billion by 2031 – TMR Study
24 mai 2023 04h30 HE | Transparency Market Research
Wilmington, Delaware, United States, May 24, 2023 (GLOBE NEWSWIRE) -- The global bare metal stents market is projected to flourish at a CAGR of 5.2% from 2023 to 2031. As per the report published by...
Anthos Logo Transparent.png
New Assessment Scale to Measure Adherence to Oral Anticoagulants Based on Impact of Patient Relevant Bleeding in Atrial Fibrillation Presented at ISPOR 2023
09 mai 2023 09h45 HE | Anthos Therapeutics
Anticoagulant Bleeding Burden Adherence Confidence Assessment Scale [ABBA-CAS] Created to Better Address an Important Treatment Gap in the Management of Atrial Fibrillation (AF) and Bring Patient...
Anthos Logo Transparent.png
New Assessment Scale to Capture Patient Relevant Bleeding to be Presented at ISPOR 2023
05 mai 2023 08h00 HE | Anthos Therapeutics
Additional presentation spotlights GARDENIA registry design in patientswith atrial fibrillation and atrial flutter Early Cost-Effectiveness Modeling for Patients with Atrial Fibrillation and Cancer...
Dr. Erik Tucker, CEO of Aronora
Aronora CEO Named National Academy of Inventors Fellow
08 déc. 2022 10h00 HE | Aronora, Inc
PORTLAND, Ore., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Erik Tucker, Ph.D., joins an elite group of inventors with his election to the National Academy of Inventors. Dr. Tucker's research into blood...
Aronora logo
Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
06 déc. 2022 07h00 HE | Aronora, Inc
PORTLAND, Ore., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Aronora Inc., a clinical-stage biotechnology company developing next-generation therapeutics for blood clotting diseases, announced today that...